These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10846548)

  • 1. Alteration of the p53 gene of lung carcinomas with sarcomatous transformation (spindle cell carcinoma): analysis of four cases.
    Kawano R; Takeshima Y; Inai K
    Pathol Int; 1996 Jan; 46(1):38-45. PubMed ID: 10846548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung.
    Murase T; Takino H; Shimizu S; Inagaki H; Tateyama H; Takahashi E; Matsuda H; Eimoto T
    Hum Pathol; 2003 Nov; 34(11):1178-84. PubMed ID: 14652820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung.
    Yamasaki M; Takeshima Y; Fujii S; Matsuura M; Tagawa K; Inai K
    Pathol Int; 2000 Nov; 50(11):891-6. PubMed ID: 11107065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
    Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomatous transformation of EGFR and TP53 mutation-positive metastatic adenocarcinoma of the lungs, masquerading as a primary pleomorphic sarcoma of the proximal femur.
    Toda-Ishii M; Akaike K; Kurisaki-Arakawa A; Arakawa A; Mukaihara K; Suehara Y; Takagi T; Kaneko K; Yao T; Saito T
    Int J Clin Exp Pathol; 2015; 8(3):3270-8. PubMed ID: 26045851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trichilemmal carcinoma arising from a proliferating trichilemmal cyst: the loss of the wild-type p53 is a critical event in malignant transformation.
    Takata M; Rehman I; Rees JL
    Hum Pathol; 1998 Feb; 29(2):193-5. PubMed ID: 9490283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wide expression of ZEB1 in sarcomatous component of spindle cell carcinoma of the esophagus.
    Nakazawa T; Nobusawa S; Ikota H; Kuwano H; Takeyoshi I; Yokoo H
    Pathol Int; 2015 Dec; 65(12):635-43. PubMed ID: 26515382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.
    Oda H; Nakatsuru Y; Ishikawa T
    Cancer Res; 1995 Feb; 55(3):658-62. PubMed ID: 7834636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
    Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
    Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy.
    Chang YL; Wu CT; Shih JY; Lee YC
    Ann Surg Oncol; 2011 Oct; 18(10):2952-60. PubMed ID: 21409490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.
    Kanazawa H; Ebina M; Ino-Oka N; Shimizukawa M; Takahashi T; Fujimura S; Imai T; Nukiwa T
    Am J Pathol; 2000 Apr; 156(4):1289-98. PubMed ID: 10751354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.
    Lien HC; Lin CW; Mao TL; Kuo SH; Hsiao CH; Huang CS
    J Pathol; 2004 Oct; 204(2):131-9. PubMed ID: 15376261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-ras mutation is an additional event of sarcomatous transformation in aerodigestive spindle cell carcinoma.
    Shiratsuchi H; Hirakawa N; Saito T; Oda Y; Yamamoto H; Tomita K; Yamamoto T; Tsuneyoshi M
    Oncol Rep; 2004 Mar; 11(3):597-604. PubMed ID: 14767509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.
    Matsumoto T; Fujii H; Arakawa A; Yamasaki S; Sonoue H; Hattori K; Kajiyama Y; Hirose S; Tsurumaru M
    Hum Pathol; 2004 Mar; 35(3):322-7. PubMed ID: 15017588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
    Busby-Earle RM; Steel CM; Williams AR; Cohen B; Bird CC
    Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome.
    Entius MM; Keller JJ; Westerman AM; van Rees BP; van Velthuysen ML; de Goeij AF; Wilson JH; Giardiello FM; Offerhaus GJ
    J Clin Pathol; 2001 Feb; 54(2):126-31. PubMed ID: 11215281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations.
    Iwao T; Hanada K; Tsuchida A; Hirata M; Eguchi N; Kajiyama G
    Cancer; 1998 Apr; 82(8):1487-94. PubMed ID: 9554525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
    Nishisaka T; Takeshima Y; Inai K
    Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.